`
`Paper No. _____
`Date Filed: January 26, 2015
`
`
`Filed on behalf of: INO Therapeutics LLC
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`________________
`
`Praxair Distribution, Inc.
`Petitioner,
`v.
`INO Therapeutics LLC
`Patent Owner.
`________________
`
`Case IPR2015-00522
`U.S. Patent No. 8,282,966
`________________
`
`
`INO THERAPEUTICS LLC
`MANDATORY NOTICES – 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8, INO Therapeutics LLC (the “Patent Owner”),
`
`as indicated by the assignment recorded at Reel/Fame 032411/0246 and
`
`028834/0483 submits the following Mandatory Notices.
`
`Real Party-In-Interest (37 C.F.R. § 42.8 (b)(1)):
`
`Pursuant to the requirements of 37 C.F.R. § 42.8(a)(2), the real party-in-
`
`interest is INO Therapeutics LLC (the “Patent Owner”). Ikaria, Inc., an affiliate of
`
`INO Therapeutics LLC, is also a real party-in-interest.
`
`Related Matters (37 C.F.R. § 42.8 (b)(2)):
`
`INO Therapeutics LLC is not aware of any judicial or administrative matter
`
`that would affect, or be affected by, a decision in the instant proceeding. There are
`
`no pending patent applications that claim the benefit of the priority of the filing
`
`date of the subject patent.
`
`Designation of Lead and Back-Up Counsel (37 C.F.R. § 42.8(b)(3)):
`
`Lead counsel is Dominick A. Conde (Reg. No. 33,856) and back-up counsel
`
`is Raymond R. Mandra (Reg. No. 34,382). William E. Solander is also designated
`
`as back-up counsel requiring pro hac vice admission to appear in this proceeding.
`
`A power of attorney from INO Therapeutics LLC is being submitted with
`
`this Notice.
`
`
`
`
`
`
`
`- 2 -
`
`
`
`
`
`
`Service Information (37 C.F.R. § 42.8(b)(4)):
`
`INO Therapeutics LLC may be served by postal mailing, hand-delivery,
`
`telephone or facsimile as follows:
`
`Dominick A. Conde
`
`FITZPATRICK, CELLA, HARPER & SCINTO
`
`1290 Avenue of the Americas
`
`New York, NY 10104-3800
`
`Telephone:
`
`(212) 218-2100
`
`Facsimile:
`
`(212) 218-2200
`
`INO Therapeutics LLC may be served electronically using the following e-
`
`mail addresses:
`
`
`
`
`
`
`
`dconde@fchs.com (lead counsel)
`
`rmandra@fchs.com (back-up counsel)
`
`wsolander@fchs.com (back-up counsel)
`
`
`
`- 3 -
`
`
`
`
`
`
`Any questions concerning this paper may be directed to lead counsel listed
`
`below.
`
`January 26, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
` /Dominick A. Conde/
`Dominick A. Conde (Reg. No. 33,856)
`Lead Counsel for Patent Owner
`FITZPATRICK, CELLA, HARPER & SCINTO
`Tel: (212) 218-2100
`
`Attorneys for Patent Owner,
`INO Therapeutics LLC
`
`Back-up Counsel:
`Raymond R. Mandra (Reg. No. 34,382)
`William E. Solander
`FITZPATRICK, CELLA, HARPER & SCINTO
`1290 Avenue of the Americas
`New York, NY 10104-3800
`(212) 218-2100
`
`
`- 4 -
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`I certify that a copy of the Patent Owners’ Mandatory Notices Under 37
`
`C.F.R. § 42.8(a)(2) was served on January 26, 2015 by causing it to be sent by
`
`email to counsel for Petitioner at the following email addresses:
`
`sanjay.murthy@klgates.com
`
`sara.kerrane@klgates.com
`
`michael.abernathy@klgates.com
`
`Respectfully submitted,
`
` /Dominick A. Conde/
`Dominick A. Conde (Reg. No. 33,856)
`FITZPATRICK, CELLA, HARPER & SCINTO
`1290 Avenue of the Americas
`New York, NY 10104-3800
`Tel: (212) 218-2100
`
`
`January 26, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`FCHS_WS 11087647v1.doc
`
`- 5 -
`
`
`